ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 998

Mental Health in Patients with Axial Spondyloarthritis: Increasing Our Understanding of the Disease. Results from the Spanish Atlas

Marco Garrido-Cumbrera1, Victoria Navarro-Compán2, David Galvez-Ruiz1, Carlos Jesus Delgado Dominguez1, Pilar Font-Ugalde3, Olta Brace1, Pedro Zarco4, Jorge Chacon-Garcia1 and Pedro Plazuelo-Ramos5, 1Universidad de Sevilla, Seville, Spain, 2Rheumatology, Hospital Universitario La Paz, Madrid, Spain, 3Rheumatology service, IMIBIC/Reina Sofia Hospital/University of Cordoba, Cordoba, Spain, 4H Fundación Alcorcón, Alcorcón, Spain, 5CEADE, Madrid, Spain

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: mental health, psychological well-being and spondylarthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 6, 2017

Title: Epidemiology and Public Health Poster II: Rheumatic Diseases Other than Rheumatoid Arthritis

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: This study’s aim was to assess the association between sociodemographic characteristics, disease progression, and mental health comorbidity with risk of mental disorders (RMD).

Methods: In 2016 a sample of 680 axSpA patients was interviewed as part of the Spanish Atlas. To quantify the RMD, Goldberg’s General Health Questionnaire (GHQ-12) scale was employed. Possible RMD predictors analysed were: sociodemographic characteristics (age, gender, being part of a couple, patient association membership, job status); disease characteristics (BASDAI, spinal stiffness ranging from 0-3, functional limitation in 18 daily activities ranging from 0-3); and mental health comorbidities (depression and anxiety). All clinical variables showed a Cronbach’s alpha coefficient guaranteeing the reliability of the scales used. First, a descriptive analysis was employed to describe the sample and study variables. Second, we performed univariate correlation and homogeneity analyses between each predictor (independent variable) and RMD (GHQ-12). Third, selection of variables that showed statistical significance in the univariate analyses in order to conduct a multiple hierarchical and stepwise regression analysis.

Results: All variables except educational level and thoracic stiffness showed significant univariant correlation with RMD. BASDAI, functional limitation and age showed higher coefficient (R = 0.543, R = 0.378, R = -0.174, respectively). Multiple Hierarchical regression analysis showed as sociodemographic variables explained in great detail the RMD (R2 = 83.2%). By contrast, having established sociodemographic as a control variable, the inclusion of depression and anxiety to the model increase the R2 value to just 0.6% (p = 0.001), while the inclusion of variables related to the disease characteristics add 5.5% (p = 0.000) to the GHQ-12 punctuation variability. The only variables presenting a significant coefficient different from 0 were BASDAI (0.52, p = 0.000) and functional limitation (0.14, p = 0.004). This suggests that once the sociodemographic and mental commorbidity variables are established, a change to BASDAI levels or functional limitation impacts the GHQ-12 score. In the stepwise regression analysis, four variables (BASDAI, functional limitation, association membership, cervical stiffness) showed a significant relation to GHQ-12 and explained the majority of RMD variability. BASDAI displayed the highest explanatory degree (R2 = 0.875).

Table 1. Sample characteristics (n = 474, unless other specified).

Variables

Values (means ± SD or percentage)

Age, mean ± SD

45.43 ± 10.78

Sex, No. of men

233 (49.16%)

Having a couple, No. of participants (N=444)

386 (86.94%)

Education level, No. of university studies

185 (39.30%)

Job status, No. of unemployed

68 (14.35%)

Association Membership

227 (47.89%)

BASDAI, mean ± SD (N=442)

5.49 ± 2.17

Cervical stiffness, No. (N=447)

201 (44.97%)

Thoracic stiffness No. (N=435)

186 (42.76%)

Lumbar stiffness No. (N=458)

288 (62.88%)

Functional Limitation, mean ± SD (N=473)

27.54 ± 12.78

Depression, No. (%) (N=474)

99 (20.89)

Anxiety, No. (%) (N=474)

134 (28.27)

GHQ-12, mean ± SD

18.30 ± 8.01

Conclusion: Patients at certain sociodemographic levels are more prone to present a higher BASDAI. Taking these conditions for granted, the degree of disease progression measured by BASDAI is a good indicator of RMD. Therefore, in those with higher disease activity, psychiatric evaluation and intervention should be considered within the medical treatment.


Disclosure: M. Garrido-Cumbrera, None; V. Navarro-Compán, None; D. Galvez-Ruiz, None; C. J. Delgado Dominguez, None; P. Font-Ugalde, None; O. Brace, None; P. Zarco, None; J. Chacon-Garcia, None; P. Plazuelo-Ramos, None.

To cite this abstract in AMA style:

Garrido-Cumbrera M, Navarro-Compán V, Galvez-Ruiz D, Delgado Dominguez CJ, Font-Ugalde P, Brace O, Zarco P, Chacon-Garcia J, Plazuelo-Ramos P. Mental Health in Patients with Axial Spondyloarthritis: Increasing Our Understanding of the Disease. Results from the Spanish Atlas [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/mental-health-in-patients-with-axial-spondyloarthritis-increasing-our-understanding-of-the-disease-results-from-the-spanish-atlas/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/mental-health-in-patients-with-axial-spondyloarthritis-increasing-our-understanding-of-the-disease-results-from-the-spanish-atlas/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology